BrainsWay (ADR) (BWAY)
Sells and leases Deep TMS systems for clinically regulated mental-health treatment.
$13.61
After hours−0.05 (−0.37%)
At close$13.66(+0.66%)
In millions of USD, except per-share figures
| In millions | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8 | 9 | 9 | 10 | 11 | 11 | 12 | 13 | 14 | 15 | 16 | 17 |
| Cost of revenue | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 4 |
| Gross profit | 6 | 7 | 7 | 8 | 8 | 9 | 9 | 9 | 10 | 11 | 12 | 13 |
| 6 | −3 | 7 | 7 | 7 | 8 | 8 | 9 | 9 | 9 | 10 | 11 | |
| Research & development | 2 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 |
| 5 | 5 | 5 | 5 | 6 | 6 | 6 | 7 | 7 | 7 | 7 | 7 | |
| Selling & marketing | 4 | −7 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 0 |
| General & administrative | 1 | 12 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 0 |
| Other expenses | 0 | −10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating income | 0 | 10 | 0 | 1 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 2 |
| 0 | −10 | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 1 | 0 | 1 | |
| Interest income | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 1 |
| Other non-operating income | 0 | 9 | −1 | −1 | −1 | 0 | −1 | −2 | −1 | −1 | −1 | 0 |
| Income before tax | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 2 | 2 | 3 | 2 | 3 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 2 | 2 | 3 | 2 | 3 |
| Net income | 0 | 0 | 0 | 1 | 1 | 2 | 1 | 2 | 2 | 3 | 2 | 3 |
| EPS, basic | −$0.01 | $0.00 | $0.00 | $0.02 | $0.04 | $0.04 | $0.03 | $0.05 | $0.04 | $0.16 | $0.12 | $0.14 |
| EPS, diluted | −$0.01 | $0.00 | $0.00 | $0.02 | $0.04 | $0.04 | $0.02 | $0.05 | $0.04 | $0.14 | $0.12 | $0.14 |
| Weighted average shares, basic | 33 | 33 | 33 | 33 | 33 | 38 | 37 | 38 | 38 | 18 | 19 | 20 |
| Weighted average shares, diluted | 33 | 33 | 33 | 33 | 33 | 38 | 37 | 38 | 38 | 21 | 19 | 20 |
| EBITDA | 0 | 2 | 1 | 1 | 2 | 1 | 2 | 3 | 3 | 3 | 3 | 3 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | 0 | 1 | 1 | 1 | 1 | 1 | 2 | 3 | 2 | 3 | 3 | 2 |